Streetbeat News

Products Services

DOGEUSD

Dogecoin's daily active users have surged by 32% in the last 24 hours, reaching 55,444 addresses. This increase in network activity could potentially lead to a rise in DOGE's price, which is currently up 2.10% at $0.101. Market observers are watching for a break above the daily SMA 50 at $0.115, which could trigger a new uptrend.

Portfolio Pulse from Bibhu Pattnaik

August 17, 2024 | 6:29 pm

BTCUSD

Real Vision analyst Jamie Coutts predicts that Bitcoin (BTC) could surge by 200% in its current cycle if the U.S. Dollar Index (DXY) drops significantly below 101. This forecast is based on continued central bank injections, particularly from the Bank of Japan (BoJ) and the People's Bank of China (PBoC), which have significantly contributed to global liquidity.

Portfolio Pulse from Bibhu Pattnaik

August 17, 2024 | 5:45 pm

MJUS

MSOS

The article discusses the growing support for cannabis legalization in key battleground states, the potential impact of Florida's upcoming vote on recreational cannabis, and the rapid growth of Georgia's medical marijuana program. It also highlights the performance of cannabis-related ETFs like MSOS and MJUS, and the issuance of adult-use cannabis licenses in New York.

Portfolio Pulse from Todd Harrison

August 17, 2024 | 3:17 pm

AAPL

Apple Inc. is reportedly developing a tabletop robot, a significant shift in its product strategy. The device, featuring a large display and a robotic arm, could be released by 2026 or 2027 with a price tag around $1,000. While top Apple executives support the project, some analysts are skeptical about its success, comparing it to Meta's discontinued Portal. The success or failure of this product could have major implications for Apple's future direction.

Portfolio Pulse from Bibhu Pattnaik

August 17, 2024 | 2:45 pm

F

GM

GOEV

KARS

LCID

RIVN

TSLA

The article discusses the latest developments in the electric vehicle (EV) sector, highlighting Tesla's market share erosion, Lucid's technological advancements, Rivian's production halt, and recalls by Ford and GM. It also mentions Canoo's financial performance and the performance of various EV stocks over the week.

Portfolio Pulse from Shanthi Rexaline

August 17, 2024 | 12:30 pm

RIVN

Rivian Automotive (NASDAQ:RIVN) has launched a $1,400 travel kitchen designed for its R1 vehicles, which can also be used with other power sources. This new product aligns with Rivian's adventure-focused branding and follows the recent launch of the second generation of R1 vehicles. The company plans to start production of a lower-priced R2 SUV in 2026.

Portfolio Pulse from Anan Ashraf

August 17, 2024 | 7:46 am

TSLA

Tesla CEO Elon Musk envisions a future where humans can upload their memories to the cloud and download them into humanoid robots, enhancing the capabilities of Tesla's Optimus bots. Musk believes this technology could lead to a $25 trillion market cap for Optimus, significantly higher than the autonomous vehicle market. Tesla plans to have useful humanoid robots in low production by next year and aims for high-volume production by 2026.

Portfolio Pulse from Anan Ashraf

August 17, 2024 | 4:58 am

TSLA

Elon Musk's biographer, Ashlee Vance, highlighted Tesla's significant advantage in bridging AI and the physical world due to its factories. An unnamed AI expert emphasized that Tesla's ability to test humanoid robots in its own factories gives it a unique edge over competitors. Vance also compared Musk's network of companies to General Electric, noting the benefits of having a common CEO who can mobilize resources across different ventures.

Portfolio Pulse from Anan Ashraf

August 17, 2024 | 3:14 am

SPRC

SciSparc shares are trading higher following the announcement of an Exclusive Patent License Agreement with Polyrizon for the out-licensing of its SCI-160 program aimed at treating pain.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 8:36 pm

SPRC

SciSparc Ltd. (NASDAQ: SPRC) has finalized an exclusive global out-licensing agreement with Polyrizon Ltd. for its SCI-160 pain therapy program. The deal is valued at $3 million in Polyrizon shares, with potential additional cash payments and fees if development milestones are met.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 8:36 pm